Comment on Goldfine et al. Targeting inflammation using salsalate in patients with type 2 diabetes: effects on flow-mediated dilation (TINSAL-FMD). Diabetes care 2013;36:4132-4139

Letter/Communication

Open access

Gary L Pierce, Kyle Siefers and Lauren Wegman-Points

Diabetes care, Vol.37(5), pp.e110-e111

05/2014

DOI: 10.2337/dc13-2781

PMCID: PMC4876757

PMID: 24757238

Files and links (1)

url

https://doi.org/10.2337/dc13-2781View

Published (Version of record) Open Access

Diabetes Mellitus, Type 2 - blood

Inflammation - drug therapy

Humans

Salicylates - administration & dosage

Endothelium, Vascular - physiopathology

Female

Male

Vasodilation - drug effects

Blood Glucose - metabolism

Title: Subtitle: Comment on Goldfine et al. Targeting inflammation using salsalate in patients with type 2 diabetes: effects on flow-mediated dilation (TINSAL-FMD). Diabetes care 2013;36:4132-4139
Creators: Gary L Pierce
Kyle Siefers
Lauren Wegman-Points
Resource Type: Letter/Communication
Publication Details: Diabetes care, Vol.37(5), pp.e110-e111
DOI: 10.2337/dc13-2781
PMID: 24757238
PMCID: PMC4876757
NLM abbreviation: Diabetes Care
ISSN: 0149-5992
eISSN: 1935-5548
Publisher: United States
Grant note: P01 HL014388 / NHLBI NIH HHS
Language: English
Date published: 05/2014
Academic Unit: Health, Sport, and Human Physiology ; Internal Medicine
Record Identifier: 9984002337602771

21 Record Views